药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxamniquine
4-hydroxycoumarin
The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Nilotinib.
Oxamniquine
Diphenadione
The risk or severity of bleeding can be increased when Diphenadione is combined with Nilotinib.
Oxamniquine
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Nilotinib.
Oxamniquine
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Nilotinib.
Oxamniquine
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Nilotinib.
Oxamniquine
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Nilotinib.
Oxamniquine
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Nilotinib.
Oxamniquine
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Nilotinib.
Oxamniquine
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Nilotinib.
Oxamniquine
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Nilotinib.
Oxamniquine
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Nilotinib.
Oxamniquine
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Nilotinib.
Oxamniquine
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Nilotinib.
Oxamniquine
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Nilotinib.
Oxamniquine
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Nilotinib.
Oxamniquine
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Nilotinib.
Oxamniquine
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Nilotinib.
Oxamniquine
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Nilotinib.
Oxamniquine
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Nilotinib.
Oxamniquine
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Nilotinib.